Article

Adding trastuzumab to standard chemotherapy in HER2-positive esophagogastric adenocarcinoma: a further step toward personalized medicine.

Medizinische Klinik 1, Klinikum der Johann Wolfgang Goethe-Universit├Ąt, Frankfurt am Main, Germany
Gastroenterology (Impact Factor: 12.82). 11/2010; 140(1):356-8; discussion 358. DOI: 10.1053/j.gastro.2010.11.011
Source: PubMed
0 Bookmarks
 · 
44 Views